MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, PBYI has $216,302K in assets. $85,962K in debts. $29,635K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
200.22%
Quick Ratio
193.43%
Cash Ratio
36.47%
Debt to Asset Ratio
39.74%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Accounts receivable, net of allo...
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses, current
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
29,635
Marketable securities
67,893
Accounts receivable, net of allowance for credit loss of 0 and 362
53,654
Inventory
5,515
Prepaid expenses, current
3,642
Restricted cash, current
2,091
Other assets, current
256
Total current assets
162,686
Lease right-of-use assets, net
5,373
Property, plant and equipment, gross
4,785
Less accumulated depreciation
4,598
Property and equipment, net
187
Intangible assets, net
41,392
Restricted cash, long-term
0
Deferred tax assets
3,830
Prepaid expenses and other, long-term
2,834
Total assets
216,302
Accounts payable
5,056
Accrued expenses, current
50,031
Lease liabilities, current
1,314
Post-marketing commitment liability
2,187
Current portion of long-term debt
22,523
Other liabilities, current
142
Total current liabilities
81,253
Lease liabilities, long-term
4,709
Post-marketing commitment liability, long-term
0
Total long-term debt, net
0
Other liabilities, long-term
0
Total liabilities
85,962
Common stock - .0001 par value per share 100,000,000 shares authorized 50,408,023 shares issued and outstanding at december 31, 2025 and 49,105,834 issued and outstanding at december 31, 2024
5
Additional paid-in capital
1,414,074
Accumulated other comprehensive income
36
Accumulated deficit
-1,283,775
Total stockholders equity
130,340
Total liabilities and stockholders equity
216,302
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$67,893K Accounts receivable, netof allowance for...$53,654K Cash and cashequivalents$29,635K Inventory$5,515K Prepaid expenses,current$3,642K Restricted cash, current$2,091K Other assets, current$256K Property, plant andequipment, gross$4,785K Total current assets$162,686K Intangible assets, net$41,392K Lease right-of-useassets, net$5,373K Deferred tax assets$3,830K Prepaid expenses andother, long-term$2,834K Property and equipment,net$187K Less accumulateddepreciation$4,598K Total assets$216,302K Total liabilities andstockholders equity$216,302K Total stockholdersequity$130,340K Total liabilities$85,962K Accumulated deficit-$1,283,775K Additional paid-in capital$1,414,074K Total currentliabilities$81,253K Lease liabilities,long-term$4,709K Accumulated othercomprehensive income$36K Common stock - .0001 parvalue per share...$5K Accrued expenses,current$50,031K Current portion oflong-term debt$22,523K Accounts payable$5,056K Post-marketing commitmentliability$2,187K Lease liabilities,current$1,314K Other liabilities,current$142K

PUMA BIOTECHNOLOGY, INC. (PBYI)

PUMA BIOTECHNOLOGY, INC. (PBYI)